JPMorgan Chase & Co’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$167K Buy
34,379
+18,094
+111% +$88.1K ﹤0.01% 4545
2025
Q1
$60.3K Sell
16,285
-939,647
-98% -$3.48M ﹤0.01% 4960
2024
Q4
$3.82M Buy
955,932
+945,863
+9,394% +$3.78M ﹤0.01% 2953
2024
Q3
$70.2K Buy
10,069
+447
+5% +$3.12K ﹤0.01% 4869
2024
Q2
$54.6K Sell
9,622
-60,655
-86% -$344K ﹤0.01% 4869
2024
Q1
$936K Buy
70,277
+70,144
+52,740% +$934K ﹤0.01% 3611
2023
Q4
$817 Hold
133
﹤0.01% 5824
2023
Q3
$335 Hold
133
﹤0.01% 5817
2023
Q2
$697 Hold
133
﹤0.01% 5600
2023
Q1
$1K Hold
133
﹤0.01% 5678
2022
Q4
$1K Sell
133
-294
-69% -$2.21K ﹤0.01% 5482
2022
Q3
$3K Buy
427
+109
+34% +$766 ﹤0.01% 5282
2022
Q2
$3K Sell
318
-2,417
-88% -$22.8K ﹤0.01% 5381
2022
Q1
$50K Sell
2,735
-2,435
-47% -$44.5K ﹤0.01% 5012
2021
Q4
$136K Buy
5,170
+3,641
+238% +$95.8K ﹤0.01% 4709
2021
Q3
$55K Hold
1,529
﹤0.01% 4933
2021
Q2
$84K Sell
1,529
-5,142
-77% -$282K ﹤0.01% 4821
2021
Q1
$553K Sell
6,671
-4,106
-38% -$340K ﹤0.01% 3991
2020
Q4
$1.22M Buy
10,777
+3,464
+47% +$393K ﹤0.01% 3259
2020
Q3
$225K Sell
7,313
-5,269
-42% -$162K ﹤0.01% 3688
2020
Q2
$553K Sell
12,582
-5,438
-30% -$239K ﹤0.01% 3267
2020
Q1
$646K Buy
18,020
+10,845
+151% +$389K ﹤0.01% 3187
2019
Q4
$479K Sell
7,175
-633
-8% -$42.3K ﹤0.01% 3445
2019
Q3
$1.21M Buy
7,808
+436
+6% +$67.6K ﹤0.01% 2973
2019
Q2
$559K Sell
7,372
-495
-6% -$37.5K ﹤0.01% 3333
2019
Q1
$1.09M Sell
7,867
-109,958
-93% -$15.2M ﹤0.01% 2986
2018
Q4
$47.4M Sell
117,825
-86,113
-42% -$34.6M 0.01% 818
2018
Q3
$144M Sell
203,938
-9,149
-4% -$6.47M 0.03% 516
2018
Q2
$114M Sell
213,087
-9,687
-4% -$5.18M 0.02% 560
2018
Q1
$25.1M Buy
+222,774
New +$25.1M 0.01% 1235